Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04906863 · ClinicalTrials.gov registry record
Genetic Studies of Early-onset Dementia
A clinical trial of Dementia, Early Onset, sponsored by Columbia University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT04906863 is a study of Dementia, Early Onset that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04906863, a study of Dementia, Early Onset, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
Conditions Studied
Interventions
- GENETIC Blood draw
- OTHER Neurocognitive testing
- OTHER Medical questionnaire
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-09-14 |
| Est. Completion | 2028-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04906863
The ClinicalTrials.gov registry entry for NCT04906863 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dementia, Early Onset appearing as the primary indexed condition, and to 3 interventions - of which Blood draw is the first listed.
NCT04906863 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04906863 about?
NCT04906863 is a clinical study titled "Genetic Studies of Early-onset Dementia". The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
What is the current status of trial NCT04906863?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-09-14. Estimated completion is 2028-04-30.
What conditions does trial NCT04906863 study?
This clinical trial studies the following conditions: Dementia, Early Onset.
What interventions are being tested in trial NCT04906863?
The interventions under investigation include: Blood draw (GENETIC), Neurocognitive testing (OTHER), Medical questionnaire (OTHER).
Who is sponsoring clinical trial NCT04906863?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04906863 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.